STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] LINDE PLC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Guillermo Bichara, Executive Vice President & Chief Legal Officer of Linde plc (LIN), reported insider transactions dated 09/11/2025. The filing shows a gift disposition of 640 ordinary shares (transaction code G) with $0 received, reducing direct holdings to 22,137.769 ordinary shares. The report also discloses 2,890.178 shares held indirectly in a 401(k) plan. The Form 4 lists outstanding equity awards: restricted stock units totaling 4,863 RSUs scheduled to vest between 2026 and 2028, multiple stock options exercisable through 2035 representing specified share counts, and 794.534 deferred stock units payable one-for-one in ordinary shares under the company deferral plan.

Positive
  • Continued substantial equity alignment through direct ownership, RSUs, deferred stock units, and multiple long-dated stock options
  • Routine, transparent Section 16 disclosure with clear vesting schedules and indirect 401(k) holdings
Negative
  • Disposition of 640 ordinary shares as a gift reported with $0 proceeds
  • No information on beneficiary or recipient of the gifted shares is provided in the filing

Insights

TL;DR: Routine insider reporting shows a small gift disposition and sustained equity alignment with company compensation plans.

The Form 4 documents a gift of 640 shares by an officer and detailed holdings of equity awards and deferred units. The filing is standard in format and content for Section 16 reporting and confirms the reporting person's ongoing economic exposure through direct ownership, indirect 401(k) holdings, unvested RSUs, deferred stock units, and long-dated stock options. There is no indication of sales for cash proceeds or unusual transactions. From a governance perspective, continued ownership and deferred awards align management incentives with shareholders.

TL;DR: Transaction is immaterial to capital structure; options and RSUs indicate multi-year compensation exposure.

The disclosed grant and outstanding option schedule show staged vesting through 2035 and multiple strike prices. The gift removal of 640 shares at $0 reduces direct holdings but is not presented as a market sale. Reported derivative holdings include specified option lots and RSUs totaling 4,863 vested/vesting units plus 794.534 deferred units. These holdings imply a multi-year compensation profile rather than a near-term liquidity event. No cash proceeds or exercised-for-cash transactions are reported.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Bichara Guillermo

(Last) (First) (Middle)
C/O LINDE PLC
FORGE, 43 CHURCH STREET WEST

(Street)
WOKING SURREY X0 GU216HT

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Exec VP & Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 09/11/2025 G 640(1) D $0 22,137.769 D
Ordinary Shares 2,890.178 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) (2) (2) Ordinary Shares 1,613 1,613 D
Restricted Stock Units (3) (3) (3) Ordinary Shares 1,570 1,570 D
Restricted Stock Units (4) (4) (4) Ordinary Shares 1,680 1,680 D
Stock Options (right to buy) $468.77 (5) 03/07/2035 Ordinary Shares 11,326 11,326 D
Stock Options (right to buy) $465.29 (6) 03/07/2034 Ordinary Shares 10,345 10,345 D
Stock Options (right to buy) $354.14 (7) 03/07/2033 Ordinary Shares 11,085 11,085 D
Stock Options (right to buy) $270.99 (8) 03/07/2032 Ordinary Shares 13,280 13,280 D
Stock Options (right to buy) $253.68 (9) 03/08/2031 Ordinary Shares 20,975 20,975 D
Stock Options (right to buy) $173.13 (10) 03/09/2030 Ordinary Shares 26,155 26,155 D
Stock Options (right to buy) $154 (11) 02/27/2028 Ordinary Shares 38,800 38,800 D
Deferred Stock Units (12) (13) (13) Ordinary Shares 794.534 794.534 D
Explanation of Responses:
1. Gift of shares; no market transaction occurred.
2. Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
3. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
4. Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
5. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
6. This option vested in full over three years in three consecutive equal annual installments beginning one year after the date of the grant.
7. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
8. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
9. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
10. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
11. This option vested over three years in three consecutive equal annual installments beginning on February 27, 2019.
12. Conversion to Linde plc Ordinary Shares is on a one-to-one basis.
13. Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.
Remarks:
Anthony M. Pepper as attorney-in-fact 09/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Guillermo Bichara report in the Form 4 for Linde plc (LIN)?

The filing reports a gift disposition of 640 ordinary shares on 09/11/2025, reducing direct holdings to 22,137.769 shares, plus 2,890.178 shares held indirectly in a 401(k).

Was there any cash received from the transaction reported on the Form 4?

No; the disposition is coded as a gift with a reported price of $0, indicating no cash proceeds.

What equity awards does the Form 4 disclose for the reporting person?

The Form 4 lists restricted stock units vesting in 2026–2028 (totaling 4,863 RSUs), multiple stock options with exercise prices and expirations through 2035, and 794.534 deferred stock units payable one-for-one in ordinary shares.

Does the filing indicate any exercises or market sales of options?

No; the filing shows outstanding stock options and vesting schedules but does not report any option exercises or market sales.

Who signed the Form 4 and when was it submitted?

The filing was signed by Anthony M. Pepper as attorney-in-fact on 09/15/2025.
Linde Plc

NASDAQ:LIN

LIN Rankings

LIN Latest News

LIN Latest SEC Filings

LIN Stock Data

200.15B
465.67M
0.26%
87.42%
1.13%
Specialty Chemicals
Industrial Inorganic Chemicals
Link
United Kingdom
WOKING SURREY